Heterogeneous tumor vasculature in retinoblastoma: Implications for vessel targeting therapy

Maria Elena Jockovich, Yolanda Piña, Armando Alegret, Colleen Cebulla, William J Feuer, Timothy G. Murray

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

PURPOSE: The aim of this study is to correlate tumor size of retinoblastoma tumor samples with blood vessel maturation to assess how these factors may affect vessel targeting therapy. METHODS: Analysis was performed on retinoblastoma tumor specimens (n = 5) enucleated as primary treatment from May 2005 to February 2006. Tumor size was measured as the largest cross sectional area of the tumor, measured during pathologic assessment. Vessel density and heterogeneity was measured by immunohistochemical analysis. Total microvessel density was detected by staining endothelial cells using a lectin from Bandeira simplicifolia; novel vasculature was detected with the endothelial cell marker endoglin (CD105). Blood vessel basement membrane was detected with an antibody against type IV collagen. Vessel maturation was assessed by pericyte recruitment, detected with α smooth muscle actin (α-sma). RESULTS: A statistically significant correlation was detected between tumor burden and age at enucleation (P = 0.008). All retinoblastoma tumor samples harbored a high degree of blood vessel heterogeneity containing both immature neovessels as well as pericyte-committed mature vasculature. There was a statistically significant correlation between type IV collagen and age at enucleation (P = 0.045). CONCLUSIONS: This study provides a framework for a better understanding of tumor and vessel development in retinoblastoma. Results of this study provide insight into the relationship between age and tumor burden in these tumors. Knowledge of the degree of heterogeneity detected in these tumors will aid in the selection of novel blood vessel targeting strategies for children with this disease and other diseases with pathologic neovascularization.

Original languageEnglish (US)
JournalRetina
Volume28
Issue number3 SUPPL.
DOIs
StatePublished - Mar 2008

Fingerprint

Retinoblastoma
Neoplasms
Blood Vessels
Pericytes
Therapeutics
Collagen Type IV
Tumor Burden
Endothelial Cells
Pathologic Neovascularization
Microvessels
Lectins
Basement Membrane
Smooth Muscle
Actins
Staining and Labeling
Antibodies

Keywords

  • Blood vessel maturation
  • Retinoblastoma
  • Tumor and vessel development
  • Tumor size

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Jockovich, M. E., Piña, Y., Alegret, A., Cebulla, C., Feuer, W. J., & Murray, T. G. (2008). Heterogeneous tumor vasculature in retinoblastoma: Implications for vessel targeting therapy. Retina, 28(3 SUPPL.). https://doi.org/10.1097/IAE.0b013e318150d6f0

Heterogeneous tumor vasculature in retinoblastoma : Implications for vessel targeting therapy. / Jockovich, Maria Elena; Piña, Yolanda; Alegret, Armando; Cebulla, Colleen; Feuer, William J; Murray, Timothy G.

In: Retina, Vol. 28, No. 3 SUPPL., 03.2008.

Research output: Contribution to journalArticle

Jockovich, ME, Piña, Y, Alegret, A, Cebulla, C, Feuer, WJ & Murray, TG 2008, 'Heterogeneous tumor vasculature in retinoblastoma: Implications for vessel targeting therapy', Retina, vol. 28, no. 3 SUPPL.. https://doi.org/10.1097/IAE.0b013e318150d6f0
Jockovich, Maria Elena ; Piña, Yolanda ; Alegret, Armando ; Cebulla, Colleen ; Feuer, William J ; Murray, Timothy G. / Heterogeneous tumor vasculature in retinoblastoma : Implications for vessel targeting therapy. In: Retina. 2008 ; Vol. 28, No. 3 SUPPL.
@article{a3d0d97a72984803abc7a054973b2b9c,
title = "Heterogeneous tumor vasculature in retinoblastoma: Implications for vessel targeting therapy",
abstract = "PURPOSE: The aim of this study is to correlate tumor size of retinoblastoma tumor samples with blood vessel maturation to assess how these factors may affect vessel targeting therapy. METHODS: Analysis was performed on retinoblastoma tumor specimens (n = 5) enucleated as primary treatment from May 2005 to February 2006. Tumor size was measured as the largest cross sectional area of the tumor, measured during pathologic assessment. Vessel density and heterogeneity was measured by immunohistochemical analysis. Total microvessel density was detected by staining endothelial cells using a lectin from Bandeira simplicifolia; novel vasculature was detected with the endothelial cell marker endoglin (CD105). Blood vessel basement membrane was detected with an antibody against type IV collagen. Vessel maturation was assessed by pericyte recruitment, detected with α smooth muscle actin (α-sma). RESULTS: A statistically significant correlation was detected between tumor burden and age at enucleation (P = 0.008). All retinoblastoma tumor samples harbored a high degree of blood vessel heterogeneity containing both immature neovessels as well as pericyte-committed mature vasculature. There was a statistically significant correlation between type IV collagen and age at enucleation (P = 0.045). CONCLUSIONS: This study provides a framework for a better understanding of tumor and vessel development in retinoblastoma. Results of this study provide insight into the relationship between age and tumor burden in these tumors. Knowledge of the degree of heterogeneity detected in these tumors will aid in the selection of novel blood vessel targeting strategies for children with this disease and other diseases with pathologic neovascularization.",
keywords = "Blood vessel maturation, Retinoblastoma, Tumor and vessel development, Tumor size",
author = "Jockovich, {Maria Elena} and Yolanda Pi{\~n}a and Armando Alegret and Colleen Cebulla and Feuer, {William J} and Murray, {Timothy G.}",
year = "2008",
month = "3",
doi = "10.1097/IAE.0b013e318150d6f0",
language = "English (US)",
volume = "28",
journal = "Retina",
issn = "0275-004X",
publisher = "Lippincott Williams and Wilkins",
number = "3 SUPPL.",

}

TY - JOUR

T1 - Heterogeneous tumor vasculature in retinoblastoma

T2 - Implications for vessel targeting therapy

AU - Jockovich, Maria Elena

AU - Piña, Yolanda

AU - Alegret, Armando

AU - Cebulla, Colleen

AU - Feuer, William J

AU - Murray, Timothy G.

PY - 2008/3

Y1 - 2008/3

N2 - PURPOSE: The aim of this study is to correlate tumor size of retinoblastoma tumor samples with blood vessel maturation to assess how these factors may affect vessel targeting therapy. METHODS: Analysis was performed on retinoblastoma tumor specimens (n = 5) enucleated as primary treatment from May 2005 to February 2006. Tumor size was measured as the largest cross sectional area of the tumor, measured during pathologic assessment. Vessel density and heterogeneity was measured by immunohistochemical analysis. Total microvessel density was detected by staining endothelial cells using a lectin from Bandeira simplicifolia; novel vasculature was detected with the endothelial cell marker endoglin (CD105). Blood vessel basement membrane was detected with an antibody against type IV collagen. Vessel maturation was assessed by pericyte recruitment, detected with α smooth muscle actin (α-sma). RESULTS: A statistically significant correlation was detected between tumor burden and age at enucleation (P = 0.008). All retinoblastoma tumor samples harbored a high degree of blood vessel heterogeneity containing both immature neovessels as well as pericyte-committed mature vasculature. There was a statistically significant correlation between type IV collagen and age at enucleation (P = 0.045). CONCLUSIONS: This study provides a framework for a better understanding of tumor and vessel development in retinoblastoma. Results of this study provide insight into the relationship between age and tumor burden in these tumors. Knowledge of the degree of heterogeneity detected in these tumors will aid in the selection of novel blood vessel targeting strategies for children with this disease and other diseases with pathologic neovascularization.

AB - PURPOSE: The aim of this study is to correlate tumor size of retinoblastoma tumor samples with blood vessel maturation to assess how these factors may affect vessel targeting therapy. METHODS: Analysis was performed on retinoblastoma tumor specimens (n = 5) enucleated as primary treatment from May 2005 to February 2006. Tumor size was measured as the largest cross sectional area of the tumor, measured during pathologic assessment. Vessel density and heterogeneity was measured by immunohistochemical analysis. Total microvessel density was detected by staining endothelial cells using a lectin from Bandeira simplicifolia; novel vasculature was detected with the endothelial cell marker endoglin (CD105). Blood vessel basement membrane was detected with an antibody against type IV collagen. Vessel maturation was assessed by pericyte recruitment, detected with α smooth muscle actin (α-sma). RESULTS: A statistically significant correlation was detected between tumor burden and age at enucleation (P = 0.008). All retinoblastoma tumor samples harbored a high degree of blood vessel heterogeneity containing both immature neovessels as well as pericyte-committed mature vasculature. There was a statistically significant correlation between type IV collagen and age at enucleation (P = 0.045). CONCLUSIONS: This study provides a framework for a better understanding of tumor and vessel development in retinoblastoma. Results of this study provide insight into the relationship between age and tumor burden in these tumors. Knowledge of the degree of heterogeneity detected in these tumors will aid in the selection of novel blood vessel targeting strategies for children with this disease and other diseases with pathologic neovascularization.

KW - Blood vessel maturation

KW - Retinoblastoma

KW - Tumor and vessel development

KW - Tumor size

UR - http://www.scopus.com/inward/record.url?scp=42949160613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42949160613&partnerID=8YFLogxK

U2 - 10.1097/IAE.0b013e318150d6f0

DO - 10.1097/IAE.0b013e318150d6f0

M3 - Article

C2 - 18317352

AN - SCOPUS:42949160613

VL - 28

JO - Retina

JF - Retina

SN - 0275-004X

IS - 3 SUPPL.

ER -